NearWave is a hardware company that develops a noninvasive breast cancer chemotherapy monitoring device. The device combines a form of infrared spectroscopy and novel photo sensors to detect cancer markers. This is done by measuring the characteristic absorption and scatter of light from biological molecules which are indicative of cancer. NearWave’s technology can predict cancer therapy nonresponse within seven days, allowing for rapid, personalized drug regimens.